Recent Updates
Recently added Catalysts
XENE Positive Sentiment Score: 75/100

Xenon Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference

Wednesday, June 5, 2024 1 min read
Key Takeaway: Xenon Pharmaceuticals Inc. announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference, scheduled for June 10-13, 2024, in Miami, FL. The company's presentation will take place on June 12, 2024, at 4:00 pm Eastern Time and will feature CEO Ian Mortimer and CCO Chris Von Seggern. A live webcast of the presentation will be available on the company's website, with an option for replay afterward. This event highlights Xenon's commitment to advancing treatments for neurological and psychiatric disorders.

Market Sentiment Analysis

POSITIVE FACTORS

  • Xenon Pharmaceuticals is actively engaging with investors at a high-profile healthcare conference.
  • The company's focus on developing therapeutics for neurological and psychiatric disorders addresses significant medical needs.
  • Live webcast allows for broader investor access and engagement.

Full Press Release Details

VANCOUVER, British Columbia, June 05, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced that the company will present at the Goldman Sachs 45th Annual Global Healthcare Conference taking place June 10-13, 2024 in Miami, FL.
Fireside Chat Presentation Details:
Date: Wednesday, June 12, 2024
Time: 4:00 pm Eastern Time
Webcast: Register here
Presenters: Ian Mortimer, President and Chief Executive Officer Chris Von Seggern, Chief Commercial Officer
A live webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals (Nasdaq:XENE) is a neuroscience-focused biopharmaceutical company committed to discovering, developing, and commercializing innovative therapeutics to improve the lives of people living with neurological and psychiatric disorders. We are advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Vice President, Investor Relations
investors@xenon-pharma.com
Xenon Corporate Affairs
media@xenon-pharma.com

Frequently Asked Questions

When will Xenon Pharmaceuticals present at the conference?

Xenon Pharmaceuticals will present on June 12, 2024.

Who are the presenters at the Goldman Sachs conference?

Ian Mortimer and Chris Von Seggern will present.

Where can I watch the live webcast of Xenon's presentation?

The webcast will be available on Xenon's website under the 'Investors' section.

What is the focus of Xenon Pharmaceuticals?

Xenon is focused on developing therapies for neurological and psychiatric disorders.

What types of conditions does Xenon aim to address?

Xenon aims to address epilepsy and depression among other conditions.

Tags: XENE Viatris Investor Conferences Healthcare Xenon Pharmaceuticals epilepsy depression Goldman Sachs healthcare conference
Last updated: Jun 5, 2024